CLINORIL Trademark

Trademark Overview

On Tuesday, September 22, 2020, a trademark application was filed for CLINORIL with the United States Patent and Trademark Office. The USPTO has given the CLINORIL trademark a serial number of 90198743. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 18, 2023. This trademark is owned by Galt Pharmaceuticals. The CLINORIL trademark is filed in the Pharmaceutical Products category with the following description:

Analgesic, antipyretic and anti-inflammatory agent
clinoril

General Information

Serial Number90198743
Word MarkCLINORIL
Filing DateTuesday, September 22, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 18, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 16, 2021

Trademark Statements

Goods and ServicesAnalgesic, antipyretic and anti-inflammatory agent

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, October 29, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGalt Pharmaceuticals
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressAtlanta, GA 30339
Party NameGalt Pharmaceuticals
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressMarietta, GA 30067

Trademark Events

Event DateEvent Description
Monday, December 18, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, December 18, 2023ABANDONMENT - NO USE STATEMENT FILED
Thursday, June 29, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 28, 2023SOU EXTENSION 4 GRANTED
Thursday, May 11, 2023SOU EXTENSION 4 FILED
Monday, June 26, 2023NOTICE OF REVIVAL - E-MAILED
Monday, June 26, 2023SOU EXTENSION RECEIVED WITH TEAS PETITION
Monday, June 26, 2023PETITION TO REVIVE-GRANTED
Monday, June 26, 2023TEAS PETITION TO REVIVE RECEIVED
Monday, June 12, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, June 12, 2023ABANDONMENT - NO USE STATEMENT FILED
Tuesday, February 7, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 6, 2023SOU EXTENSION 3 GRANTED
Monday, November 14, 2022SOU EXTENSION 3 FILED
Monday, February 6, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, December 5, 2022NOTICE OF REVIVAL - E-MAILED
Monday, December 5, 2022SOU EXTENSION RECEIVED WITH TEAS PETITION
Monday, December 5, 2022PETITION TO REVIVE-GRANTED
Monday, December 5, 2022TEAS PETITION TO REVIVE RECEIVED
Wednesday, May 11, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 9, 2022SOU EXTENSION 2 GRANTED
Monday, May 9, 2022SOU EXTENSION 2 FILED
Monday, May 9, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, November 3, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 1, 2021SOU EXTENSION 1 GRANTED
Monday, November 1, 2021SOU EXTENSION 1 FILED
Monday, November 1, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, May 11, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 16, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 16, 2021PUBLISHED FOR OPPOSITION
Wednesday, February 24, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, February 8, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, February 1, 2021ASSIGNED TO EXAMINER
Thursday, October 29, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Related Keywords

clinoril agent inflammatory anti antipyretic analgesic